Back
Brookfield Asset Management Vs. Xtacy Therapeutics Industry Stock Comparison
Buy
80
BAM.TO
Brookfield Asset Management
Last Price:
63.50
Seasonality Move:
3.97%
Sell
27
XTCY.CX
Xtacy Therapeutics
Last Price:
0.03
Seasonality Move:
43.46%
Buy
80
Brookfield Asset Management (BAM.TO)
is a Buy
Is Brookfield Asset Management a Buy, Sell or Hold?
- The current Brookfield Asset Management [BAM.TO] share price is $63.50. The Score for BAM.TO is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- BAM.TO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
Xtacy Therapeutics (XTCY.CX)
is a Sell
Is Xtacy Therapeutics a Buy, Sell or Hold?
- The current Xtacy Therapeutics [XTCY.CX] share price is $0.03. The Score for XTCY.CX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- XTCY.CX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BAM.TO Stock Price Chart
What is Brookfield Asset Management's stock price today?
-
The Brookfield Asset Management share price today is $63.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BAM.TO is experiencing selling pressure, which indicates risk of future bearish movement.
XTCY.CX Stock Price Chart
What is Xtacy Therapeutics's stock price today?
-
The Xtacy Therapeutics share price today is $0.03
The current trend is relatively stagnant and XTCY.CX is experiencing slight buying pressure.
BAM.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.03 | Buy |
Relative Strength Index (14 RSI): | 72.34 | Buy |
Chaikin Money Flow: | -3081325 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.48 - 60.78) | Buy |
Bollinger Bands (100): | (52.41 - 57.97) | Buy |
XTCY.CX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 44.83 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.02 - 0.04) | Sell |
Bollinger Bands (100): | (0.03 - 0.05) | Sell |
BAM.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.92 | Buy |
20-day SMA: | 58.3 | Buy |
50-day SMA: | 57.12 | Buy |
200-day SMA: | 54.56 | Buy |
8-day EMA: | 61.79 | Buy |
20-day EMA: | 59.36 | Buy |
50-day EMA: | 57.26 | Buy |
200-day EMA: | 53.81 | Buy |
XTCY.CX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.03 | Sell |
20-day SMA: | 0.03 | Sell |
50-day SMA: | 0.03 | Sell |
200-day SMA: | 0.04 | Sell |
8-day EMA: | 0.02 | Buy |
20-day EMA: | 0.03 | Sell |
50-day EMA: | 0.03 | Sell |
200-day EMA: | 0.05 | Sell |
Brookfield Asset Management Earnings Growth & BAM.TO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.09 per share, an increase this year of $0.08 per share, and an increase next year of $0.36 per share.
Xtacy Therapeutics Earnings Growth & XTCY.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Brookfield Asset Management Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Xtacy Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |